Opens in a new tab

Meril Italy v Edwards Lifesciences (CFI, 23 September 2024)

Date23 September 2024
CourtCFI
DivisionParis (FR) Central Division - Seat
Type of actionApplication RoP262.1 (b)
Registry referenceApp_33484/2024 · ORD_36092/2024
PartiesKIPA AB

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 23 September 2024 (UPC_CFI_189/2024, ACT_22275/2024, App_33484/2024, ORD_36092/2024), the judge-rapporteur of panel 2 of the Paris Central Division (P. Catallozzi) refused a request for access to all written pleadings and evidence in the action for revocation of EP 4 151 181 brought by Meril Italy srl, Meril GmbH and Meril Life Sciences Pvt Ltd against Edwards Lifesciences Corporation. The request came from SWAT Medical AB and an individual describing himself as a board member and investor. The order makes clear that the interest relied on by a third party must be shown, not merely asserted.

Question

Can a third party claiming to be a competitor with an interest in the patent’s validity obtain access, under Rule 262.1(b), to the pleadings and evidence of pending proceedings?

Decision

Openness is the principle (Art. 10(1) and Art. 45 UPCA), subject to a balancing against the interests of the parties and third parties, the integrity of the proceedings and public order (paragraphs 8 to 11). The applicant must state the purpose of the request and why the documents are needed (paragraph 12). A competitor or licensee may have a direct interest in validity, including while proceedings are pending (paragraph 13), but being active in the same field is not enough: the applicant had not shown that it competed with the parties (paragraphs 14 and 15). A general interest in information does not outweigh the protection of the integrity of the pending proceedings (paragraphs 16 and 17), nor the protection of personal interests (paragraph 18).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 10(1) and Art. 45
Rules of Procedure
Rule 262.1(b)
Case law cited
Ocado Innovation v Autostore, Court of Appeal, 10 April 2024, Vienna Local Division, 12 August 2024, UPC_CFI_33/2024, Nordic-Baltic Regional Division, 17 September 2024, UPC_CFI_8/2023

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Confidentiality club.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Application RoP262.1 (b)
Outcome (Dhenne Avocats summary)
La demande d'accès aux écritures et pièces est rejetée : la qualité de concurrent n'est pas établie et l'intérêt général d'information ne l'emporte pas sur l'intégrité de la procédure en cours.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 151 181Mentioned in the analysis (role not qualified)
Also mentioned in 4 other decision(s): Meril Life Sciences v Edwards Lifesciences (CFI, 20 October 2025) · Meril Italy v SWAT Medical (CFI, 8 January 2025) · Edwards Lifesciences v Meril Life Sciences (CFI, 8 October 2024) · Meril Life Sciences v Edwards Lifesciences (CFI, 17 September 2024)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.